Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS-CoV-2 Infection

Review Cardiac & Cardiovascular Systems

Coronavirus Disease 2019 and the Athletic Heart Emerging Perspectives on Pathology, Risks, and Return to Play

Jonathan H. Kim et al.

Summary: This study addresses the impact of COVID-19 infection on cardiac pathology among patients, particularly in athletes. Despite lacking definitive data, it suggests a conservative return-to-play approach and cardiac risk assessment for athletes following COVID-19 recovery.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening

Matthew W. Martinez et al.

Summary: This study assessed the prevalence of relevant COVID-19-associated cardiac pathology in professional athletes and found few cases of inflammatory heart disease. Most athletes were able to safely return to professional sports activities after cardiac screening.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes

Nathaniel Moulson et al.

Summary: This study investigated the prevalence and clinical implications of COVID-19 cardiac involvement in young competitive athletes in the United States. The results showed a low prevalence of cardiac involvement and a low risk of clinical events in short-term follow-up among these athletes.

CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection Results From the Big Ten COVID-19 Cardiac Registry

Curt J. Daniels et al.

Summary: In this study of 1597 competitive athletes in the US who underwent CMR screening after COVID-19 infection, 37 athletes (2.3%) were diagnosed with clinical and subclinical myocarditis. There was variability in prevalence across universities, and testing protocols were closely associated with the detection of myocarditis. The unique CMR imaging data highlight the need for standardized timing and interpretation of cardiac testing for safe return to play in athletes.

JAMA CARDIOLOGY (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems